Our story makes us unique.
RadioMedix operations cover the entire value chain from drug discovery to sponsoring and conducting clinical trials to scale up manufacturing. RadioMedix is compliant with 21 CFR Parts 210,211,212. The Molecular Core Facility supports the synthesis, and the pre-clinical evaluation of our drugs and contract projects. Our cGMP Suite (Headquarter) manufactures doses for the Phase I-III clinical trials. Our state of the art commercial manufacturing site is prepared for the scaled up and commercial grade production of radiolabeled drugs and isotopes (The Spica Center).
Our Experts
Ebrahim S.Delpassand MD
Founder & CEO
Founder and current Chief Executive Officer of RadioMedix. He completed his residency training in Nuclear Medicine and Anatomical and Clinical Pathology at Baylor College of Medicine.
Founder Name
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Founder Name
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Founder Name
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Founder Name
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Founder Name
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
